vpd.net
Velocity Pharmaceutical Development - We Build Drugs, Not Companies.™
http://www.vpd.net/sitemap.html
Stay Connected With Velocity. We Build Drugs, Not Companies. Velocity Pharmaceutical Development, LLC Sitemap. Leslie S. Loven. James F. Watson. Karen D. Talmadge. Samuel R. Saks. VPD 12.17.2014. VPD 12.17.2014. VPD 819.2013 737. June 15-18, 2015 Philadelphia. June 8-13, 2015 Vancouver. March 20-24, 2015 San Francisco. January 12-15, 2015 San Francisco. January 11, 2015 San Francisco. November 3-5, 2014 Frankfurt. October 14, 2014 Tokyo. October 7-8, 2014 San Francisco. September 22-24, 2014 Boston.
vpd.net
Velocity Pharmaceutical Development - We Build Drugs, Not Companies.™
http://www.vpd.net/newsroom.html
Stay Connected With Velocity. We Build Drugs, Not Companies. VPD News and Events. May 24, 2016. Thunderbolt Pharma, Inc., a Vitesse Biologics Company, Acquires Rights to BAFF/APRIL Dual Antagonist Program from Astellas Pharma Inc. June 1, 2015. Baxter Ventures, Mayo Clinic and Velocity Pharmaceutical Development announce the formation of Vitesse Biologics, LLC, a company structured to accelerate therapeutic innovation. December 17, 2014. December 17, 2014. Tigercat Pharma, Inc. launches new website.
vpd.net
Velocity Pharmaceutical Development - We Build Drugs, Not Companies.™
http://www.vpd.net/index.html
Stay Connected With Velocity. Acquires drug candidates and rely on a single expert team of experienced pharmaceutical industry veterans to rapidly move them forward to clinical proof of concept. Our model provides partners with a compelling alternative strategy for the development of their drug candidates. We build drugs, not companies. The Velocity management team has the experience, relationships and expertise to drive drugs to the key human clinical data that catalyze attractive transactions. VPD acqu...